nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—GJA1—autistic disorder	0.461	0.62	CbGaD
Carvedilol—XDH—autistic disorder	0.203	0.274	CbGaD
Carvedilol—ADRB2—autistic disorder	0.0791	0.107	CbGaD
Carvedilol—HIF1A—hindbrain—autistic disorder	0.00295	0.0315	CbGeAlD
Carvedilol—GJA1—hindbrain—autistic disorder	0.00286	0.0306	CbGeAlD
Carvedilol—VCAM1—mouth—autistic disorder	0.00269	0.0287	CbGeAlD
Carvedilol—HIF1A—mouth—autistic disorder	0.00259	0.0276	CbGeAlD
Carvedilol—GJA1—mouth—autistic disorder	0.00251	0.0268	CbGeAlD
Carvedilol—NDUFC2—mouth—autistic disorder	0.00219	0.0233	CbGeAlD
Carvedilol—VCAM1—eye—autistic disorder	0.00171	0.0183	CbGeAlD
Carvedilol—HIF1A—brainstem—autistic disorder	0.00169	0.0181	CbGeAlD
Carvedilol—HIF1A—eye—autistic disorder	0.00165	0.0176	CbGeAlD
Carvedilol—GJA1—brainstem—autistic disorder	0.00164	0.0175	CbGeAlD
Carvedilol—HIF1A—forebrain—autistic disorder	0.00163	0.0174	CbGeAlD
Carvedilol—GJA1—eye—autistic disorder	0.0016	0.0171	CbGeAlD
Carvedilol—GJA1—forebrain—autistic disorder	0.00158	0.0169	CbGeAlD
Carvedilol—NPPB—head—autistic disorder	0.00156	0.0167	CbGeAlD
Carvedilol—HIF1A—telencephalon—autistic disorder	0.0015	0.016	CbGeAlD
Carvedilol—NPPB—nervous system—autistic disorder	0.00148	0.0158	CbGeAlD
Carvedilol—GJA1—telencephalon—autistic disorder	0.00146	0.0156	CbGeAlD
Carvedilol—NPPB—central nervous system—autistic disorder	0.00143	0.0152	CbGeAlD
Carvedilol—NDUFC2—eye—autistic disorder	0.00139	0.0148	CbGeAlD
Carvedilol—NDUFC2—forebrain—autistic disorder	0.00138	0.0147	CbGeAlD
Carvedilol—SELE—digestive system—autistic disorder	0.00129	0.0138	CbGeAlD
Carvedilol—NDUFC2—telencephalon—autistic disorder	0.00127	0.0135	CbGeAlD
Carvedilol—VCAM1—digestive system—autistic disorder	0.00119	0.0127	CbGeAlD
Carvedilol—VEGFA—telencephalon—autistic disorder	0.00115	0.0123	CbGeAlD
Carvedilol—HIF1A—digestive system—autistic disorder	0.00115	0.0122	CbGeAlD
Carvedilol—NPPB—brain—autistic disorder	0.00113	0.0121	CbGeAlD
Carvedilol—GJA1—digestive system—autistic disorder	0.00111	0.0119	CbGeAlD
Carvedilol—SELE—head—autistic disorder	0.00106	0.0113	CbGeAlD
Carvedilol—SELE—nervous system—autistic disorder	0.001	0.0107	CbGeAlD
Carvedilol—VCAM1—head—autistic disorder	0.000971	0.0104	CbGeAlD
Carvedilol—NDUFC2—digestive system—autistic disorder	0.000967	0.0103	CbGeAlD
Carvedilol—SELE—central nervous system—autistic disorder	0.000964	0.0103	CbGeAlD
Carvedilol—SELE—cerebellum—autistic disorder	0.000942	0.0101	CbGeAlD
Carvedilol—HIF1A—head—autistic disorder	0.000935	0.00998	CbGeAlD
Carvedilol—VCAM1—nervous system—autistic disorder	0.000921	0.00984	CbGeAlD
Carvedilol—GJA1—head—autistic disorder	0.000907	0.00968	CbGeAlD
Carvedilol—VCAM1—central nervous system—autistic disorder	0.000887	0.00947	CbGeAlD
Carvedilol—HIF1A—nervous system—autistic disorder	0.000886	0.00946	CbGeAlD
Carvedilol—GJA1—nervous system—autistic disorder	0.00086	0.00918	CbGeAlD
Carvedilol—HIF1A—central nervous system—autistic disorder	0.000853	0.00911	CbGeAlD
Carvedilol—ADRA1A—hindbrain—autistic disorder	0.000848	0.00906	CbGeAlD
Carvedilol—HIF1A—cerebellum—autistic disorder	0.000834	0.00891	CbGeAlD
Carvedilol—GJA1—central nervous system—autistic disorder	0.000828	0.00884	CbGeAlD
Carvedilol—ADRA1D—forebrain—autistic disorder	0.000817	0.00872	CbGeAlD
Carvedilol—GJA1—cerebellum—autistic disorder	0.000809	0.00864	CbGeAlD
Carvedilol—NDUFC2—head—autistic disorder	0.000789	0.00843	CbGeAlD
Carvedilol—XDH—digestive system—autistic disorder	0.000781	0.00834	CbGeAlD
Carvedilol—SELE—brain—autistic disorder	0.000765	0.00817	CbGeAlD
Carvedilol—ADRA1D—telencephalon—autistic disorder	0.000751	0.00802	CbGeAlD
Carvedilol—NDUFC2—nervous system—autistic disorder	0.000748	0.00799	CbGeAlD
Carvedilol—Bopindolol—HTR1B—autistic disorder	0.000742	0.242	CrCbGaD
Carvedilol—NDUFC2—central nervous system—autistic disorder	0.00072	0.00769	CbGeAlD
Carvedilol—NDUFC2—cerebellum—autistic disorder	0.000704	0.00752	CbGeAlD
Carvedilol—VCAM1—brain—autistic disorder	0.000704	0.00752	CbGeAlD
Carvedilol—Tamsulosin—DRD3—autistic disorder	0.000694	0.226	CrCbGaD
Carvedilol—HIF1A—brain—autistic disorder	0.000677	0.00723	CbGeAlD
Carvedilol—GJA1—brain—autistic disorder	0.000657	0.00702	CbGeAlD
Carvedilol—VEGFA—cerebellum—autistic disorder	0.000639	0.00682	CbGeAlD
Carvedilol—CYP1A1—mouth—autistic disorder	0.000607	0.00648	CbGeAlD
Carvedilol—Bevantolol—ADRB2—autistic disorder	0.000596	0.194	CrCbGaD
Carvedilol—ADRB1—forebrain—autistic disorder	0.000593	0.00634	CbGeAlD
Carvedilol—NDUFC2—brain—autistic disorder	0.000572	0.00611	CbGeAlD
Carvedilol—Bopindolol—ADRB2—autistic disorder	0.000552	0.18	CrCbGaD
Carvedilol—ADRB1—telencephalon—autistic disorder	0.000546	0.00583	CbGeAlD
Carvedilol—VEGFA—brain—autistic disorder	0.000519	0.00554	CbGeAlD
Carvedilol—CYP2D6—hindbrain—autistic disorder	0.000499	0.00533	CbGeAlD
Carvedilol—ADRA1A—brainstem—autistic disorder	0.000486	0.00519	CbGeAlD
Carvedilol—ADRA1B—head—autistic disorder	0.000478	0.00511	CbGeAlD
Carvedilol—ADRA1A—forebrain—autistic disorder	0.000469	0.00501	CbGeAlD
Carvedilol—ADRA1D—head—autistic disorder	0.000468	0.005	CbGeAlD
Carvedilol—ADRA1B—nervous system—autistic disorder	0.000453	0.00484	CbGeAlD
Carvedilol—KCNH2—forebrain—autistic disorder	0.000453	0.00484	CbGeAlD
Carvedilol—ADRA1D—nervous system—autistic disorder	0.000443	0.00474	CbGeAlD
Carvedilol—ADRA1B—central nervous system—autistic disorder	0.000436	0.00466	CbGeAlD
Carvedilol—ADRA1A—telencephalon—autistic disorder	0.000431	0.00461	CbGeAlD
Carvedilol—ADRA1D—central nervous system—autistic disorder	0.000427	0.00456	CbGeAlD
Carvedilol—KCNH2—telencephalon—autistic disorder	0.000417	0.00445	CbGeAlD
Carvedilol—ADRA2C—telencephalon—autistic disorder	0.000411	0.00439	CbGeAlD
Carvedilol—ADRA2A—forebrain—autistic disorder	0.000357	0.00381	CbGeAlD
Carvedilol—ADRA1B—brain—autistic disorder	0.000346	0.0037	CbGeAlD
Carvedilol—ADRB1—head—autistic disorder	0.00034	0.00363	CbGeAlD
Carvedilol—ADRA1D—brain—autistic disorder	0.000339	0.00362	CbGeAlD
Carvedilol—PTGS1—forebrain—autistic disorder	0.000336	0.00359	CbGeAlD
Carvedilol—ADRA2A—telencephalon—autistic disorder	0.000328	0.0035	CbGeAlD
Carvedilol—ADRB1—nervous system—autistic disorder	0.000322	0.00344	CbGeAlD
Carvedilol—CYP2E1—telencephalon—autistic disorder	0.000321	0.00343	CbGeAlD
Carvedilol—ADRB1—central nervous system—autistic disorder	0.00031	0.00331	CbGeAlD
Carvedilol—PTGS1—telencephalon—autistic disorder	0.000309	0.0033	CbGeAlD
Carvedilol—CYP2D6—brainstem—autistic disorder	0.000286	0.00306	CbGeAlD
Carvedilol—Propranolol—HTR1B—autistic disorder	0.000278	0.0907	CrCbGaD
Carvedilol—CYP2D6—forebrain—autistic disorder	0.000276	0.00295	CbGeAlD
Carvedilol—CYP1A2—digestive system—autistic disorder	0.000272	0.00291	CbGeAlD
Carvedilol—ADRA1A—head—autistic disorder	0.000269	0.00287	CbGeAlD
Carvedilol—CYP1A1—digestive system—autistic disorder	0.000269	0.00287	CbGeAlD
Carvedilol—KCNH2—head—autistic disorder	0.000259	0.00277	CbGeAlD
Carvedilol—CYP2C9—digestive system—autistic disorder	0.000258	0.00276	CbGeAlD
Carvedilol—ADRA2C—head—autistic disorder	0.000256	0.00273	CbGeAlD
Carvedilol—ADRA1A—nervous system—autistic disorder	0.000255	0.00272	CbGeAlD
Carvedilol—CYP2D6—telencephalon—autistic disorder	0.000254	0.00271	CbGeAlD
Carvedilol—ADRB1—brain—autistic disorder	0.000246	0.00263	CbGeAlD
Carvedilol—KCNH2—nervous system—autistic disorder	0.000246	0.00263	CbGeAlD
Carvedilol—ADRA1A—central nervous system—autistic disorder	0.000245	0.00262	CbGeAlD
Carvedilol—CYP2E1—digestive system—autistic disorder	0.000245	0.00262	CbGeAlD
Carvedilol—ADRA2C—nervous system—autistic disorder	0.000243	0.00259	CbGeAlD
Carvedilol—ADRA1A—cerebellum—autistic disorder	0.00024	0.00256	CbGeAlD
Carvedilol—KCNH2—central nervous system—autistic disorder	0.000237	0.00253	CbGeAlD
Carvedilol—PTGS1—digestive system—autistic disorder	0.000236	0.00252	CbGeAlD
Carvedilol—ADRA2C—central nervous system—autistic disorder	0.000234	0.0025	CbGeAlD
Carvedilol—KCNH2—cerebellum—autistic disorder	0.000231	0.00247	CbGeAlD
Carvedilol—ADRA2C—cerebellum—autistic disorder	0.000228	0.00244	CbGeAlD
Carvedilol—CYP1A1—head—autistic disorder	0.000219	0.00234	CbGeAlD
Carvedilol—CYP1A1—nervous system—autistic disorder	0.000208	0.00222	CbGeAlD
Carvedilol—Propranolol—ADRB2—autistic disorder	0.000207	0.0675	CrCbGaD
Carvedilol—ADRA2A—head—autistic disorder	0.000204	0.00218	CbGeAlD
Carvedilol—CYP1A1—central nervous system—autistic disorder	0.0002	0.00214	CbGeAlD
Carvedilol—CYP2E1—head—autistic disorder	0.0002	0.00213	CbGeAlD
Carvedilol—ABCB1—forebrain—autistic disorder	0.000199	0.00212	CbGeAlD
Carvedilol—CYP3A4—digestive system—autistic disorder	0.000197	0.0021	CbGeAlD
Carvedilol—ADRA1A—brain—autistic disorder	0.000195	0.00208	CbGeAlD
Carvedilol—CYP2D6—digestive system—autistic disorder	0.000194	0.00207	CbGeAlD
Carvedilol—ADRA2A—nervous system—autistic disorder	0.000194	0.00207	CbGeAlD
Carvedilol—PTGS1—head—autistic disorder	0.000192	0.00206	CbGeAlD
Carvedilol—CYP2E1—nervous system—autistic disorder	0.000189	0.00202	CbGeAlD
Carvedilol—KCNH2—brain—autistic disorder	0.000188	0.00201	CbGeAlD
Carvedilol—ADRA2A—central nervous system—autistic disorder	0.000186	0.00199	CbGeAlD
Carvedilol—ADRA2C—brain—autistic disorder	0.000185	0.00198	CbGeAlD
Carvedilol—ABCB1—telencephalon—autistic disorder	0.000183	0.00195	CbGeAlD
Carvedilol—PTGS1—nervous system—autistic disorder	0.000182	0.00195	CbGeAlD
Carvedilol—CYP2E1—central nervous system—autistic disorder	0.000182	0.00195	CbGeAlD
Carvedilol—ADRA2A—cerebellum—autistic disorder	0.000182	0.00195	CbGeAlD
Carvedilol—CYP2E1—cerebellum—autistic disorder	0.000178	0.0019	CbGeAlD
Carvedilol—PTGS1—central nervous system—autistic disorder	0.000176	0.00188	CbGeAlD
Carvedilol—CYP1A1—brain—autistic disorder	0.000159	0.0017	CbGeAlD
Carvedilol—CYP2D6—head—autistic disorder	0.000158	0.00169	CbGeAlD
Carvedilol—CYP3A4—nervous system—autistic disorder	0.000152	0.00163	CbGeAlD
Carvedilol—CYP2D6—nervous system—autistic disorder	0.00015	0.0016	CbGeAlD
Carvedilol—ADRA2A—brain—autistic disorder	0.000148	0.00158	CbGeAlD
Carvedilol—CYP3A4—central nervous system—autistic disorder	0.000147	0.00157	CbGeAlD
Carvedilol—CYP2E1—brain—autistic disorder	0.000145	0.00155	CbGeAlD
Carvedilol—CYP2D6—central nervous system—autistic disorder	0.000144	0.00154	CbGeAlD
Carvedilol—CYP2D6—cerebellum—autistic disorder	0.000141	0.00151	CbGeAlD
Carvedilol—ABCB1—digestive system—autistic disorder	0.00014	0.00149	CbGeAlD
Carvedilol—PTGS1—brain—autistic disorder	0.000139	0.00149	CbGeAlD
Carvedilol—CYP2D6—brain—autistic disorder	0.000115	0.00122	CbGeAlD
Carvedilol—ABCB1—head—autistic disorder	0.000114	0.00122	CbGeAlD
Carvedilol—ABCB1—nervous system—autistic disorder	0.000108	0.00115	CbGeAlD
Carvedilol—ABCB1—central nervous system—autistic disorder	0.000104	0.00111	CbGeAlD
Carvedilol—ABCB1—cerebellum—autistic disorder	0.000102	0.00108	CbGeAlD
Carvedilol—ABCB1—brain—autistic disorder	8.25e-05	0.000881	CbGeAlD
Carvedilol—ADRA2C—Metabolism—POMC—autistic disorder	2.93e-06	1.83e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—POMC—autistic disorder	2.92e-06	1.82e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PLA2G4A—autistic disorder	2.91e-06	1.82e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—GSTM1—autistic disorder	2.91e-06	1.82e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—TSC2—autistic disorder	2.91e-06	1.82e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—PRKCB—autistic disorder	2.9e-06	1.81e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—POMC—autistic disorder	2.9e-06	1.81e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—PRKCB—autistic disorder	2.88e-06	1.79e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—ITGB3—autistic disorder	2.87e-06	1.79e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—TSC2—autistic disorder	2.87e-06	1.79e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—LEP—autistic disorder	2.85e-06	1.78e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—APOE—autistic disorder	2.85e-06	1.78e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—PRKCB—autistic disorder	2.84e-06	1.77e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—PLA2G4A—autistic disorder	2.81e-06	1.75e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—LEP—autistic disorder	2.81e-06	1.75e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—APOE—autistic disorder	2.81e-06	1.75e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—IGF1—autistic disorder	2.79e-06	1.74e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—GPX1—autistic disorder	2.79e-06	1.74e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—DHFR—autistic disorder	2.79e-06	1.74e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—MAOB—autistic disorder	2.78e-06	1.74e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—MAPK1—autistic disorder	2.78e-06	1.73e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—PIK3CG—autistic disorder	2.78e-06	1.73e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—APC—autistic disorder	2.78e-06	1.73e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—APOE—autistic disorder	2.77e-06	1.73e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—APC—autistic disorder	2.75e-06	1.72e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—PIK3CG—autistic disorder	2.75e-06	1.72e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	2.75e-06	1.72e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—EGF—autistic disorder	2.75e-06	1.71e-05	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—IL2—autistic disorder	2.74e-06	1.71e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—MEF2C—autistic disorder	2.74e-06	1.71e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—CYP19A1—autistic disorder	2.74e-06	1.71e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—MTHFR—autistic disorder	2.73e-06	1.7e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—EGF—autistic disorder	2.72e-06	1.7e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—APC—autistic disorder	2.72e-06	1.7e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—PIK3CG—autistic disorder	2.72e-06	1.7e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—PRKCB—autistic disorder	2.69e-06	1.68e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—EGF—autistic disorder	2.69e-06	1.68e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—HTR2A—autistic disorder	2.68e-06	1.67e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—IL2—autistic disorder	2.68e-06	1.67e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—ITGB3—autistic disorder	2.67e-06	1.66e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—HRAS—autistic disorder	2.66e-06	1.66e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—SERPINE1—autistic disorder	2.65e-06	1.65e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—POMC—autistic disorder	2.65e-06	1.65e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—PRKCB—autistic disorder	2.65e-06	1.65e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—POMC—autistic disorder	2.62e-06	1.63e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—POMC—autistic disorder	2.59e-06	1.61e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—TPH2—autistic disorder	2.59e-06	1.61e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—CYP19A1—autistic disorder	2.58e-06	1.61e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—MTHFR—autistic disorder	2.58e-06	1.61e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—APC—autistic disorder	2.57e-06	1.6e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—PIK3CG—autistic disorder	2.57e-06	1.6e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—CYP19A1—autistic disorder	2.56e-06	1.59e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—TSC2—autistic disorder	2.55e-06	1.59e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—DPYD—autistic disorder	2.55e-06	1.59e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—IGF1—autistic disorder	2.55e-06	1.59e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—COMT—autistic disorder	2.54e-06	1.59e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—EGF—autistic disorder	2.54e-06	1.59e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—APOE—autistic disorder	2.54e-06	1.59e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—MAPK1—autistic disorder	2.53e-06	1.58e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—GSTP1—autistic disorder	2.53e-06	1.58e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—APC—autistic disorder	2.53e-06	1.58e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—PIK3CG—autistic disorder	2.53e-06	1.58e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—MAOA—autistic disorder	2.53e-06	1.58e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—IGF1—autistic disorder	2.52e-06	1.57e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—MAPK1—autistic disorder	2.52e-06	1.57e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—MAPK1—autistic disorder	2.52e-06	1.57e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—MAPK1—autistic disorder	2.51e-06	1.56e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—EGF—autistic disorder	2.5e-06	1.56e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—PIK3CG—autistic disorder	2.5e-06	1.56e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—LEP—autistic disorder	2.49e-06	1.55e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—APOE—autistic disorder	2.49e-06	1.55e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—HTR2A—autistic disorder	2.49e-06	1.55e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—IGF1—autistic disorder	2.49e-06	1.55e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—IL2—autistic disorder	2.49e-06	1.55e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—MAPK1—autistic disorder	2.48e-06	1.54e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—CAT—autistic disorder	2.46e-06	1.54e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—POMC—autistic disorder	2.45e-06	1.53e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—SERPINE1—autistic disorder	2.42e-06	1.51e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—POMC—autistic disorder	2.41e-06	1.5e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	2.4e-06	1.5e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—COMT—autistic disorder	2.4e-06	1.5e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—APOE—autistic disorder	2.4e-06	1.49e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—SERPINE1—autistic disorder	2.39e-06	1.49e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—GSTP1—autistic disorder	2.39e-06	1.49e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—MAOA—autistic disorder	2.38e-06	1.48e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—POMC—autistic disorder	2.38e-06	1.48e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—COMT—autistic disorder	2.38e-06	1.48e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CACNA1C—autistic disorder	2.37e-06	1.48e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TSC2—autistic disorder	2.37e-06	1.48e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—GSTP1—autistic disorder	2.37e-06	1.48e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—SERPINE1—autistic disorder	2.36e-06	1.47e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—MAOA—autistic disorder	2.36e-06	1.47e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—IGF1—autistic disorder	2.36e-06	1.47e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	2.35e-06	1.47e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—PRKCB—autistic disorder	2.35e-06	1.47e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—MAPK1—autistic disorder	2.34e-06	1.46e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—PTGS2—autistic disorder	2.34e-06	1.46e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—PTGS2—autistic disorder	2.33e-06	1.45e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PLA2G4A—autistic disorder	2.33e-06	1.45e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—GSTM1—autistic disorder	2.33e-06	1.45e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—CAT—autistic disorder	2.32e-06	1.45e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—IGF1—autistic disorder	2.32e-06	1.45e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—LEP—autistic disorder	2.32e-06	1.44e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—APOE—autistic disorder	2.32e-06	1.44e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—MAPK1—autistic disorder	2.31e-06	1.44e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—CAT—autistic disorder	2.3e-06	1.44e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—PIK3CG—autistic disorder	2.29e-06	1.43e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—APC—autistic disorder	2.25e-06	1.4e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—PIK3CG—autistic disorder	2.25e-06	1.4e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—SERPINE1—autistic disorder	2.24e-06	1.39e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—HRAS—autistic disorder	2.23e-06	1.39e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—GPX1—autistic disorder	2.23e-06	1.39e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—EGF—autistic disorder	2.22e-06	1.39e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—SERPINE1—autistic disorder	2.2e-06	1.37e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—GSTM1—autistic disorder	2.19e-06	1.37e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PLA2G4A—autistic disorder	2.19e-06	1.37e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CYP19A1—autistic disorder	2.19e-06	1.36e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—POMC—autistic disorder	2.18e-06	1.36e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—PRKCB—autistic disorder	2.18e-06	1.36e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PLA2G4A—autistic disorder	2.17e-06	1.36e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—GSTM1—autistic disorder	2.17e-06	1.36e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PIK3CG—autistic disorder	2.16e-06	1.35e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—DHFR—autistic disorder	2.15e-06	1.34e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—IL2—autistic disorder	2.15e-06	1.34e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—POMC—autistic disorder	2.14e-06	1.33e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—IL6—autistic disorder	2.14e-06	1.33e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—GPX1—autistic disorder	2.1e-06	1.31e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—APC—autistic disorder	2.09e-06	1.3e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—PIK3CG—autistic disorder	2.09e-06	1.3e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—GPX1—autistic disorder	2.08e-06	1.3e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—EGF—autistic disorder	2.07e-06	1.29e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—POMC—autistic disorder	2.06e-06	1.28e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IGF1—autistic disorder	2.06e-06	1.28e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—MTHFR—autistic disorder	2.06e-06	1.28e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	2.05e-06	1.28e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—MAPK1—autistic disorder	2.05e-06	1.28e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—PTEN—autistic disorder	2.04e-06	1.27e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—HRAS—autistic disorder	2.03e-06	1.27e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—PTEN—autistic disorder	2.03e-06	1.27e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—COMT—autistic disorder	2.03e-06	1.27e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—HRAS—autistic disorder	2.02e-06	1.26e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GSTP1—autistic disorder	2.02e-06	1.26e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—PTEN—autistic disorder	2.02e-06	1.26e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—HRAS—autistic disorder	2.02e-06	1.26e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—MAOA—autistic disorder	2.02e-06	1.26e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—HRAS—autistic disorder	2.01e-06	1.26e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—HRAS—autistic disorder	1.99e-06	1.24e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—POMC—autistic disorder	1.99e-06	1.24e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CAT—autistic disorder	1.97e-06	1.23e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—IL2—autistic disorder	1.96e-06	1.22e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—SERPINE1—autistic disorder	1.96e-06	1.22e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—IL6—autistic disorder	1.95e-06	1.21e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—MTHFR—autistic disorder	1.94e-06	1.21e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—IL2—autistic disorder	1.94e-06	1.21e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—IL6—autistic disorder	1.94e-06	1.21e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—IL6—autistic disorder	1.93e-06	1.21e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—IL6—autistic disorder	1.93e-06	1.2e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—MTHFR—autistic disorder	1.92e-06	1.2e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—APOE—autistic disorder	1.91e-06	1.19e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—IL2—autistic disorder	1.91e-06	1.19e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IGF1—autistic disorder	1.91e-06	1.19e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—MAPK1—autistic disorder	1.9e-06	1.19e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—IL6—autistic disorder	1.9e-06	1.19e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—PTGS2—autistic disorder	1.9e-06	1.18e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—HRAS—autistic disorder	1.88e-06	1.17e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PLA2G4A—autistic disorder	1.86e-06	1.16e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GSTM1—autistic disorder	1.86e-06	1.16e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—HRAS—autistic disorder	1.85e-06	1.15e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—PTEN—autistic disorder	1.84e-06	1.15e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—PTEN—autistic disorder	1.82e-06	1.14e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—SERPINE1—autistic disorder	1.82e-06	1.13e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—IL2—autistic disorder	1.81e-06	1.13e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—APOE—autistic disorder	1.8e-06	1.13e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—IL6—autistic disorder	1.8e-06	1.12e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—PTEN—autistic disorder	1.8e-06	1.12e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—APOE—autistic disorder	1.79e-06	1.12e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—IL2—autistic disorder	1.78e-06	1.11e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GPX1—autistic disorder	1.78e-06	1.11e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—IL6—autistic disorder	1.77e-06	1.11e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—PTGS2—autistic disorder	1.74e-06	1.09e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PIK3CG—autistic disorder	1.73e-06	1.08e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—PTEN—autistic disorder	1.7e-06	1.06e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CYP19A1—autistic disorder	1.69e-06	1.05e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—PTEN—autistic disorder	1.68e-06	1.05e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—PTEN—autistic disorder	1.65e-06	1.03e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—HRAS—autistic disorder	1.65e-06	1.03e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—POMC—autistic disorder	1.64e-06	1.03e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PTGS2—autistic disorder	1.64e-06	1.02e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—MAPK1—autistic disorder	1.64e-06	1.02e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—MTHFR—autistic disorder	1.64e-06	1.02e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PIK3CG—autistic disorder	1.63e-06	1.02e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PIK3CG—autistic disorder	1.61e-06	1.01e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IL2—autistic disorder	1.58e-06	9.87e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—IL6—autistic disorder	1.57e-06	9.82e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—COMT—autistic disorder	1.57e-06	9.77e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GSTP1—autistic disorder	1.56e-06	9.73e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—MAOA—autistic disorder	1.56e-06	9.71e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—POMC—autistic disorder	1.55e-06	9.66e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—POMC—autistic disorder	1.54e-06	9.58e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—HRAS—autistic disorder	1.53e-06	9.53e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—APOE—autistic disorder	1.53e-06	9.53e-06	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—PTEN—autistic disorder	1.52e-06	9.47e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CAT—autistic disorder	1.52e-06	9.47e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—MAPK1—autistic disorder	1.5e-06	9.33e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—PTEN—autistic disorder	1.49e-06	9.28e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—MAPK1—autistic disorder	1.48e-06	9.24e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IL2—autistic disorder	1.47e-06	9.17e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—MAPK1—autistic disorder	1.46e-06	9.13e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—IL6—autistic disorder	1.46e-06	9.12e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GSTM1—autistic disorder	1.43e-06	8.94e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PLA2G4A—autistic disorder	1.43e-06	8.94e-06	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PTEN—autistic disorder	1.43e-06	8.93e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—MAPK1—autistic disorder	1.38e-06	8.63e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—PTEN—autistic disorder	1.38e-06	8.63e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PIK3CG—autistic disorder	1.38e-06	8.6e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GPX1—autistic disorder	1.37e-06	8.56e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—MAPK1—autistic disorder	1.36e-06	8.5e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—HRAS—autistic disorder	1.32e-06	8.22e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—POMC—autistic disorder	1.31e-06	8.19e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PTGS2—autistic disorder	1.31e-06	8.18e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—MTHFR—autistic disorder	1.27e-06	7.9e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—IL6—autistic disorder	1.26e-06	7.87e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PTGS2—autistic disorder	1.24e-06	7.71e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PTGS2—autistic disorder	1.23e-06	7.64e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—MAPK1—autistic disorder	1.21e-06	7.55e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—HRAS—autistic disorder	1.2e-06	7.49e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—HRAS—autistic disorder	1.19e-06	7.42e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—APOE—autistic disorder	1.18e-06	7.36e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—HRAS—autistic disorder	1.18e-06	7.33e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—IL6—autistic disorder	1.15e-06	7.17e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PTEN—autistic disorder	1.14e-06	7.13e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—IL6—autistic disorder	1.14e-06	7.1e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—MAPK1—autistic disorder	1.12e-06	7.01e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—IL6—autistic disorder	1.12e-06	7.01e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—HRAS—autistic disorder	1.11e-06	6.93e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—HRAS—autistic disorder	1.09e-06	6.82e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PTEN—autistic disorder	1.08e-06	6.72e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PTEN—autistic disorder	1.07e-06	6.66e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PIK3CG—autistic disorder	1.06e-06	6.64e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—IL6—autistic disorder	1.06e-06	6.63e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PTGS2—autistic disorder	1.05e-06	6.53e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—IL6—autistic disorder	1.05e-06	6.53e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—POMC—autistic disorder	1.01e-06	6.32e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—HRAS—autistic disorder	9.72e-07	6.06e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IL6—autistic disorder	9.3e-07	5.8e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PTEN—autistic disorder	9.13e-07	5.7e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—HRAS—autistic disorder	9.03e-07	5.63e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IL6—autistic disorder	8.64e-07	5.39e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PTGS2—autistic disorder	8.08e-07	5.04e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PTEN—autistic disorder	7.05e-07	4.4e-06	CbGpPWpGaD
